Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

Completed · Phase 1

Conditions studied: HIV Infections

In brief

To evaluate how the drug dextran sulfate (DS) is absorbed by the stomach and intestines when taken by mouth. To evaluate its effect on blood coagulation. DS has been reported to have anti-HIV activity. However, it is not known how much of the drug is absorbed into the bloodstream and can be used by the body when DS is taken by mouth.

Key facts

Study ID
NCT00000690
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
6
Expected to finish
1989-10-01
Last updated by the study team
2021-11-02

Who can join

Age: 18 and older, up to 40. Sex: male. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.